BCRX
BIOCRYST PHARMACEUTICALS INCData as of 2026 Q1 (03-31) · 13F snapshot
Summary
BIOCRYST PHARMACEUTICALS INC (BCRX) is held by 6 tracked hedge-fund managers, a combined reported value of ~$40.98M; the largest are Ken Griffin, Steven Cohen, Renaissance Technologies. This quarter: 3 added, 2 trimmed, 1 closed. 4 members of Congress have disclosed STOCK Act trades. Data as of 2026 Q1, from public SEC 13F filings, delayed up to ~45 days.
Attention · MediumThis quarter · Mixed
Gurus holding6
Congress trades4
Price$9.29vs quarter-end-2.42%
Sectors0
This quarter's moves
Top holderKen GriffinNew0
Added3
Trimmed / sold3
Value $1.33M— of portfolio139,3182026 Q1
Value $1.24M— of portfolio130,0002026 Q1
Value $541.5K— of portfolio56,8852026 Q1
Value $474.0K— of portfolio56,8002023 Q1
| Investor | Value | % of portfolio | Action |
|---|---|---|---|
| Ken GriffinPUT | $1.33M | — | — |
| Izzy EnglanderCALL | $1.24M | — | — |
| Ken GriffinCALL | $541.5K | — | — |
| Izzy EnglanderPUT | $474.0K | — | — |
Data from public SEC 13F & STOCK Act filings, delayed up to ~45 days, partial holdings only — for research, not investment advice.